Overview: Discusses strategies to overcome the blood-brain-barrier.Comparative evaluation of the present state of drug delivery strategies.Biological carriers, prodrug and chemical delivery/targeting strategies.Hypo- or hypersecretion, alteration in storage, release, catabolism, and post-translational processing of neuropeptides are associated with the etiology of many diseases affecting the central nervous system (CNS). Various peptides native to the brain and the spinal cord, as well as various synthetic peptides, peptide analogues and peptidomimetics developed as their agonists or antagonis
|